| ［1］ Wang M, Xie C, Cai RL, et al. Studies on antioxidant activities of breviscapine in the cellfree system［J］. Am J Chin Med, 2008, 36(6): 11991207.
［2］ Shi GF, Yao RX, Wang GY, et al. Liquid chromatographytandem mass spectrometry screening method for the detection of radicalscavenging natural antioxidants from the whole scutellariae (radix, stem and leaf)［J］. J Chromatogr Sci, 2015, In press.
［3］ Tian JF, Li JD, Lei Y. Clinical features of acute myocardial infarction inpatients in 26 level three class A Chinese medicine hospitals in China and the investigation of treatment［J］. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2012, 32(3): 329332.
［4］ Sang Z, Li Y, Qiang X, et al. Multifunctional scutellarinrivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer′s disease［J］. Bioorg Med Chemlett, 2015, 23(4): 668680.
［5］ Li J, Lu J, Zhang H. Functional recovery after scutellarin treatment in transient cerebral ischemic rats: a pilot study with (18)Ffluorodeoxyglucose micropet［J］. Evid Based Complement Altemat Med, 2013, 2013: 507091.
［6］ Niu C, Sheng Y, Yang R, et al. Scutellarin protects against the liver injury induced by Diosbulbin B in mice and its mechanism［J］. J Ethnopharmacol, 2015, 164(22): 301308.
［7］ 李俊玫. 野黄芩苷对人舌鳞癌Tca8113细胞细胞周期及Fas/FasL介导的细胞凋亡的影响［J］. 实用口腔医学杂志, 2013, 29(2): 250252.
［8］ Yang B, Zhao YL, Yang X, et al. Scutellarincyclodextrin conjugates: Synthesis, characterization and anticancer activity［J］. Carbohyd Polym, 2013, 92(2): 13081314.
［9］ Jiang RJ, Yang B, Liu ZK, et al. A novel polyrotaxanebased delivery system for scutellarin: preparation, characterization, and in vitro evaluation［J］. Carbohyd Res, 2013, 380(18): 149155.
［10］ Xu HT, Zhang SY. Scutellarininduced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway［J］. Phytother Res, 2013, 27(10): 15241528.
［11］ Wu Y, Fan Q, Lu N, et al. Breviscapineinduced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity［J］. Phytother Res, 2010, 24(8): 11881194.
［12］ Yang XK, Xu MY, Xu GS, et al. In vitro and in vivo antitumor activity of scutebarbatine A on human lung carcinoma A549 cell Lines［J］. Molecules, 2014, 19(7): 87408751.
［14］ Feng Y, Zhang S, Tu J, et al. Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells［J］. Leuk Lymphoma, 2012, 53(12): 24562464.
［15］ 张颖, 孙立新, 杨宁, 等. 野黄芩苷对人舌鳞癌Tca8113细胞survivin及caspase8表达的影响［J］. 实用口腔医学杂志, 2013, 29(3): 372374.
［16］ Li HX, Fan HX, Wang Z, et al. Potentiation of scutellarin on human tongue carcinoma xenograft by lowintensity ultrasound［J］. PLoS One, 2013, 8(3): e59473.
［17］ Li H, Huang D, Gao Z, et al. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase2 and 9 and αvβ6 integrin［J］. Int J Oncol, 2013, 42(5): 16741681.
［18］ Li H, Huang D, Gao Z, et al. Scutellarin inhibits cell migration by regulating production of αvβ6 integrin and Ecadherin in human tongue cancer cells［J］. Oncol Rep, 2010, 24(5): 11531160.
［19］ 张跃, 张科, 赵琦, 等.半枝莲抑制胃癌SGC7901细胞浸润转移作用及机理［J］. 时珍国医国药, 2012, 23(11): 26922694.
［20］ Raguz S, Randle RA, Sharpe ER, et al. Production of Pglycoprotein from the MDR1 upstream promoter is insufficient to affect the response to firstline chemotherapy in advanced breast cancer［J］. Int J Cancer, 2008, 122(5): 10581067.
［21］ Li L, Yi T, Lam CW. Inhibition of human efflux transporter ABCC2 (MRP2) by selfemulsifying drug delivery dystem: influences of concentration and combination of excipients［J］. J Pharm Pharm Sci, 2014, 17(4): 447460.
［22］ Li J, Wang Y, Lei JC, et al. Sensitisation of ovarian cancer cells to cisplatin by flavonoids from Scutellaria barbata［J］. Nat Prod Res, 2014, 28(10): 683689.
［23］ Chan JY, Tan BKH, Lee SC. Scutellarin sensitizes drugevoked colon cancer cell apoptosis through enhanced caspase6 activation［J］. Anticancer Res, 2009, 29(8): 30433047. |
